Abstract: Cellular protein degradation systems are necessary to avoid the accumulation of misfolded or damaged proteins. Deficiency in these systems might cause to partial degradation of misfolded proteins and generation of amyloidogenic fragments. Protein misfolding is believed to be the primary cause of neurodegenerative disorders such as Alzheimer's disease (AD). In this study, we investigate effect of two anionic peptide fragments including, an acidic fragment of human A (A 1-11) and a phosphorylated fragment of -Casein (Tetraphosphopeptide), on tau protein aggregation. According to our results, these peptide fragments, induced tau fibrillization in vitro. In sum, we suggest that structural and conformational characters of inducer are as important as charge distribution on anionic inducer molecules however more experiments would be need to exactly confirm this suggestion.
INTRODUCTION
Protein misfolding and aggregation are the most common causes of neurodegenerative disorders such as Alzheimer's disease (AD) [1] . AD is a progressive, neurodegenerative disorder that causes disruptions in memory and cognition [2] . Pathologically, AD is characterized by the accumulation of protein deposits in the brain. Neurofibrillary tangles (NFTs), one of the most important neuropathological hallmarks of AD, are comprised of tau protein, a microtubule-associated protein [3] [4] [5] . Microtubule-associated tau protein belongs to a family of intrinsically disordered proteins that promotes microtubule assembly and stability [6] [7] [8] [9] . Several pathological events including genetic mutations, post-translational modifications, formation of intermolecular disulfide bridges, A -mediated toxicity and oxidative stress have been suggested to cause dissociation of tau from microtubules, misfolding and fibrillization to form NFTs [7] [8] [9] [10] [11] [12] [13] .
Several studies have shown that pathogenesis of AD is also related to a decreased proteasome activity in cortex and hippocampus of the patient's brain [14] [15] [16] [17] . It has been reported that the proteasome dysfunction and genetic mutation in ubiquitin proteasome system (UPS) contributes to the accumulation of the abnormal tau in the AD brain [17] [18] [19] . Cellular protein degradation systems are necessary to avoid the accumulation of misfolded or damaged proteins, as well as to maintain the rapid turnover of short-lived proteins [20] . UPS is the major protein quality control system in eukaryotic cells that involves in the degradation of misfolded and other *Address correspondence to this author at the Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran; Tel: +98 21 61112473, Fax: +98 21 66404680; E-mail: riazi@ibb.ut.ac.ir aberrant proteins [21] [22] [23] . If a misfolded protein could not be refolded physiologically, it would normally result in degradation by the UPS, chaperone-mediated autophagy, and/or selective autophagy [24, 25] .
The deficiency in normal activities of UPS and nonproteasomal proteases, such as cathepsin-D, caspases and calpain 1 causes partial degradation of neural misfolded proteins [26] . The above process, result in generation of peptide fragments could interact with tau, and therefore affect its aggregation tendency. Peptide fragment 25-35 of amyloid beta (A [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] ) is one of the fragments that have been shown to increase the tau fibrillization [27] . On the other hand, previous studies have shown that polyanionic compounds such as heparin, heparan sulfate and polyglutamic acid could induce tau filament formation [28] [29] [30] .
Based on the above studies, we were interested to investigate the effect of two anionic peptide fragments including, an acidic fragment of Human A (A [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] ) and a phosphorylated fragment of -Casein, on tau protein aggregation.
MATERIALS AND METHODS

Materials
Human A 1-11 (DAEFRHDSGYE) and Bovine -Casein (tetraphosphopeptide) (RELEELNVPGEIVE-pS-L-pS-pSpS-EESITR) were purchased from Ana Spec (San Jose, CA). The his-tagged tau DNA (1N4R) was synthesized by Uurofine MWG Operon Company (Germany). SP Sepharose and Nickel Chelatintg Sepharose were obtained from Amersham Biosciences. Thioflavine T (ThT), Thioflavine S (ThS) and Heparin were purchased from Sigma-Aldrich (Munich, Germany). All solutions were prepared by deionized water and filtered through a 0.22 m filter (Sartorius, Fed, Rep, Germany).
Expression and Purification of Tau
The his-tagged tau DNA was cloned via NdeI/ XhoI sites into pET-21a (+) expression vector and transformed into E.coli BL21 (DE3) for expression. Bacteria were grown at 37 °C in 1 liter Luria Broth with 100 g/ml ampicillin at 200 rpm to a density with an absorbance of 0.6 at 600 nm. Then, bacterial cultures were induced with IPTG at a final concentration of 1 mM. After incubation at 37 °C for 4 h, the harvested cells were resuspended in lysis buffer (20 mM Tris-HCl, 50 mM NaCl, 1mM EDTA, 5 mM DTT, 0.1 mM PMSF, pH 7.5), and then broken by sonication (Soniprep 150, MSE, UK) on ice. The filtered supernatants were loaded onto a SP Sepharose column and washed with lysis buffer. Tau protein was eluted by a linear gradient of salt (0.05-1 M NaCl) in the same buffer without DTT and EDTA. Tau containing fractions were pooled and loaded onto Nickel Chelating Sepharose column pre-equilibrated by 20 mM Tris-HCl, 0.3% Triton X-100, 0.5 M NaCl, 10 mM Imidazol, pH7.5. The unbound proteins were washed out by 20 mM Tris-HCl, 20 mM Imidazol (pH7.5) and tau containing fractions were eluted by a linear gradient of imidazol (0.02-0.6 M ). Protein concentration was determined by the Bradford assay and its purity was determined (>95%) by Coomassie Brilliant Blue staining of 10% SDS-PAGE. The purified protein was exchanged into 10 mM PBS buffer (pH 7.4) by Millipore centrifugal devices and stored at -70 °C.
Dynamic Light Scattering
The charge/size parameter of A 1-11 and -Casein were determined by ZetaPlus (zeta potential analyzer) sub application of dynamic light scattering (DLS) (Brookhaven, USA). For samples preparing, each peptide was diluted in PB+DTT buffer (10 mM NaH 2 PO 4 , 1 mM DTT) to a concentration of 15 μM.
Aggregation of Tau
Tau solutions were diluted into PB+DTT buffer (10 mM NaH 2 PO 4 , 1 mM DTT) to a concentration of 60 μM in the presence or absence of anionic peptide fragments (A 1-11 or Bovine -Casein; tetraphosphopeptide) in a tau:peptide molar ratio of 4:1 and incubated with shaking at 37 °C for 22 days.
Self Aggregation of A 1-11 and -Casein Tetraphosphopeptide
Peptide fragments were separately diluted into PB+DTT buffer (10 mM NaH 2 PO 4 , 1 mM DTT) to a concentration of 15 μM and then incubated with 1200 rpm shaking at 37 °C for 22 days. The level of aggregation was measured through ThT fluorescence intensity emission after excitation at 450 nm by Cary Eclipse Varian-spectrofluorometer.
Circular Dichroism Spectroscopy
Changes in secondary structure of samples were analyzed by circular dichroism (CD) spectroscopy. CD spectra were recorded by an Aviv model 215 Spectropolarimeter (Lakewood, NJ, USA). Measurements were performed in the spectral range of 195-260 nm using a quartz cuvette (Helma) with a path length of 1 mm on a protein concentration of 60 M. Spectra was converted from machine units in millidegrees to delta epsilons. However for detecting the secondary structural changes of peptides by CD after incubation, 15 M of human A 1-11 and Bovine -Casein were prepared.
Thioflavin T Assay
A 100 μM aqueous stock solution of ThT was prepared and filtered through a 0.2 μm filter. The different samples of Tau were diluted in 10 mM phosphate buffer (pH 7.4) to a final concentration of 5 μM. Then, 15 μl of stock ThT was added to 140 μl of each test sample. Fluorescence intensity was measured (excitation wavelength 450 nm) immediately using a Varian-spectrofluorometer (Model: Cary Eclipse).
Kinetics of Tau Aggregation
The kinetics of aggregation of the tau protein was measured by the ThS assay. Each sample contains 25 M of tau protein, 15 M of A [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] or -Casein peptide and PB+DTT buffer pH 7.4 (10 mM NaH 2 PO 4 , 1 mM DTT). Samples were incubated with 1200 rpm shaking at 37 °C. For every reading a calculated amount of the protein according to the concentration used in the aggregation experiment was withdrawn from the sample and added to ThS solution (15 M of ThS was used for each experiment). Afterward fluorescence emission intensity was measured at 512 nm after excitation at 440 nm by fluoreacence mode of Synergy H4 Hybrid Multi-Mode Microplate Reader.
Gel Electrophoresis
Tau protein samples were mixed with sample buffer (50 mM Tris-HCl pH 6.8; 2% SDS; 0.1% bromophenol blue; 10% glycerol) and boiled for 5 minutes. The samples were subjected to electrophoresis on 10% Tris-glycine SDSpolyacrylamide gel electrophoresis. The gel was stained with Coomassie Brilliant Blue.
Electron Microscopy
For analysis by transmission electron microscopy, samples were treated with 2% glutaraldehyde, spotted onto a formvar/carbon-coated 300 mesh grids, and negatively stained with 2% uranyl acetate. Samples were examined using a Philips EM208 transmission electron microscope, operated at 90 kV.
RESULTS
Neurodegenerative disorders are chronic degenerative states of the central nervous system that often cause dementia. In the most of these neurological protein misfolding diseases including AD, fragments of the disease-related protein initiate aggregation and toxicity [31] .
Despite the proven UPS and proteasome dysfunction in AD, the relationship between them has not been well understood. The formation of peptide fragments is one of the consequences of deficiency in protein degradation systems. In the present study we investigated the effects of two anionic peptide fragments on the aggregation tendency of tau by using a variety of techniques such as Far-UV CD, ThT fluorescence and gel electrophoresis as well as TEM assays.
Analyses and computational studies indicate that fibrils share a common, cross-beta structure highly enriched insheet contents [32] . Therefore, -sheet propensity can influence the structural properties of the aggregates and lead to a diverse set of supramolecular assemblies. Far-UV CD, probing the chiral environment of the amide group, is very sensitive to small changes of the secondary structure in protein aggregation. According to our results, immediately after incubation, all samples displayed a strongly negative ellipticity reading at 200 nm, indicating the presence of an unfolded state with ''random-coil properties''. After 22 days incubation, in the presence of anionic peptide fragments, tau displayed strong absorbance at 218 nm, indicating of -sheet structure. However, in tau control sample any considerable secondary structure change was not seen (Fig. 1) . To find if A 1-11 and/or -Casein tetraphosphopeptide would aggregate, Far-UV CD was employed. Results showed that two above peptides increased their random-coilness without any observable -sheet structure at 218 nm (Fig. 2) . In order to understand the relationship between tau structure and its aggregation tendency, thioflavin T (ThT) binding was measured. ThT is a dye that specifically binds to -sheet structures and widely used for the identification and quantification of amyloid fibrils [33] . In this study, in the absence of anionic peptide fragments (control sample), no considerable fluorescence intensity was observed. In contrast, these fragments significantly increased tendency of tau to form aggregates with cross-beta structure. In addition, no individual self assembly of each peptide was detected by ThT assay ( Fig. 3) . These results are in agreement with far-UV CD assays. Contribution of different samples of tau in aggregation was investigated by gel electrophoresis. Comparison of obtained data indicated that tau, in the absence of anionic peptide fragments, did not form aggregate, while, incubation of tau with these fragments resulted in a markedly decrease in monomeric tau and formation of different aggregates forms (Fig. 4) . This suggested that these anionic peptides act as inducers of tau aggregation. (1) and tau control (2), tau+A [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] (3) , tau+ -casein tetraphosphopeptide (4) after 22 days incubation at 37 °C. Tau samples (60 μM) incubated for 22 days at 37 °C and then subjected to electrophoresis on 10% polyacrilamide gel.
In addition, for the purpose of determining the morphology of the structures formed in the presence or absence of anionic peptide fragments, different tau samples were negatively stained and viewed by electron microscopy. According to our results, in the absence of anionic peptide fragments no aggregate was observed, while incubation of tau in the presence of these fragments for 22 days at 37 ºC resulted in the fibrils formation significantly (Fig. 5) .
Kinetic data obtained by coincubation of A [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] orCasein fragment with tau protein individually, showed that the rate of tau protein aggregation in the presence of each peptide did not differ, but the quantity of tau protein aggregates was shown to be higher in the presence of -Casein fragment than A [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] (Fig. 6) .
Since to investigate the effects of peptides charge/size value on tau protein aggregation, zeta potential of each peptide was determined ( Table 1) .
DISCUSSION
Physiological conditions that trigger tau fibril formation in vivo are still unknown. In vitro assembly of tau intosheet-rich fibrils is a complex process as a number of factors which have been shown to influence aggregation propensity [34, 35] . Tau protein is intrinsically disordered in solution and because of its high solubility, it is resistant to aggregation [36] . In order to aggregate tau into fibrils, the protein needs to undergo conformational change through the forma- tion of partially folded or structurally compact conformation. Several studies have shown that conformational changes of tau from random-coil to -sheet structure play a key role in the pathogenic events that occur in AD and other neurodegenerative conditions [37] [38] [39] . Therefore, any factor that affect tau protein conformational change could potentially decrease or increase its fibrils formation.
Our results provide some structural insights into the role of model anionic peptides catalyzing tau misfolding and aggregate formation. Two peptides (A 1-11 and BovineCasein; tetraphosphopeptide) were shown to interact with tau protein to bring about a conformational change to a partially folded state with a high propensity for aggregation. Mentioned anionic peptides induced structural compaction of tau protein which promoted stable tau fibrils through seeding assembly process. On the other hand, polycation induced oligomerization and accelerated fibrillation of alphasynuclein was not accompanied by significant secondary structural changes [40] . It seems that a variety of compounds with different charges and molecular size would induce conformational changes to increase aggregation tendency of tau.
At present, the interactions between these compounds and tau protein have not been well characterized, particularly when inducers are peptides or proteins. Coincubation of tau with amyloid beta (A 40 or A 42 ) [41] , as well as alphasynuclein, [42] synergistically promotes self aggregation of both proteins into the insoluble forms.
In our experiments, we did not observe any aggregated form of A [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] or -Casein tetraphosphopeptide, while these peptides were incubated individually at the same condition as tau. Therefore, coincubation of A 1-11 or -Casein fragment with tau promotes fibrillation of tau protein. In conclusion, our results are in the agreement with previous studies [28] [29] [30] , suggesting that anionic peptide fragments, could dramatically change the aggregation tendency of tau. We suggest that a single molecule of A [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] or -Casein participates in formation of tau dimer as nuclei serving as a building block for further fibril growth. Confirming to the fact that charge/size value of -Casein tetraphosphopeptide is more than heparin, kinetic data of coincubation of each molecule with tau showed that -Casein increase aggregation significantly. Although charge/size value of A 1-11 and heparin are different, however aggregation induction seems to be closed. According to our results despite the charge/size value of -Casein is 3 fold greater than A 1-11 , the aggregation induction of -Casein just 28% more than A [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . We suggest that structural and conformational characters of inducer are as important as charge distribution on anionic inducer molecules. To distinguish the mechanism of the effect of charge and structure of peptide on aggregation of tau protein further experiments would be required. 
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